Spago Nanomedical Publishes The Annual Report for 2024

LUND, SE / ACCESS Newswire / April 15, 2025 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)

Spago Nanomedical's annual report for 2024 is from today available at the company's website, https://spagonanomedical.se/investor-relations/#financial-reports

For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, mats.hansen@spagonanomedical.se

Spago Nanomedical AB is a Swedish company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise treatment and diagnosis of cancer and other debilitating diseases. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, see www.spagonanomedical.se.

FNCA Sweden AB is the Certified Adviser of the company.

Attachments

Spago Nanomedical AB Annual Report 2024

SOURCE: Spago Nanomedical

ACCESS Newswire

ACCESS Newswire is a newswire service that provides regional, national, and global news to thousands of clients worldwide. Its innovative technology paired with its expansive network of journalists and media outlets helps companies, both public and private, break through the noise of the market to share their stories and connect with their audiences.